| Code | CSB-YP015318HU |
| Abbreviation | Recombinant Human MYL9 protein (Active) |
| MSDS | |
| Size | $436 |
| Order now | |
| Image |
|
| Have Questions? | Leave a Message or Start an on-line Chat |
Myosin regulatory light chain 9 governs smooth muscle contraction through calcium-dependent phosphorylation and plays emerging roles in cancer cell motility and metastasis. This full-length mature protein (aa 2–172) demonstrates native-like folding, confirmed by functional ELISA showing dose-dependent antibody binding with an EC50 of 4.628–6.430 ng/mL when immobilized at 2 μg/mL, validating its conformational integrity for protein-protein interaction assays and antibody development workflows. The C-terminal His tag preserves the regulatory N-terminal phosphorylation sites critical for myosin II activation studies, while >95% purity and <1.0 EU/μg endotoxin meet the quality thresholds commonly required for cytoskeletal dynamics experiments and Western blot or immunofluorescence positive controls. Researchers investigating actomyosin contractility mechanisms, screening kinase inhibitors targeting MLCK-mediated phosphorylation, or mapping MYL9 binding partners in cancer invasion pathways will find this preparation supports quantitative binding assays and co-immunoprecipitation studies where conformational authenticity is essential.
There are currently no reviews for this product.